Abstract:Among all non-communicable diseases, cancer is ranked as the second most common cause of death and is rising constantly. While cancer treatments mainly include radiation therapy, chemotherapy, and surgery; chemotherapy is considered the most commonly employed and effective treatment. Most of the chemotherapeutic agents are azoles based compounds and imidazole is one such insightful azole. The anticancer properties of imidazole-based compounds have been thoroughly explored in recent years and all monosubstituted, disubstituted, trisubstituted, and tetrasubstituted imidazoles have been explored for their anticancer activities. Along with these compounds, other imidazole-based compounds like 1,3-dihydro-2H-imidazole-2-thiones, imidazolones, and poly imidazole compounds have also been explored for their anticancer activities. The activities of these compounds are heavily influenced by their structural resemblance to combretastatin 4A and ABI (2-aryl-4-benzoyl-imidazole). The lead compounds were highly active on breast, gastric, colon, ovarian, cervical, bone marrow, melanoma, prostate, lung, leukemic, neuroblastoma, liver, Ehrlich, melanoma, and pancreatic cancers. The targets of these leads like tubulin, heme oxygenases, VEGF, tyrosine kinases, EGFR, and others have also been explored. The exploration of the anticancer potential of substituted imidazole compounds is the main topic of this review including synthesis, SAR, and mechanism.

Anticancer mechanisms of β‐carbolines

Synthesis and Biological Evaluation of Bivalent Β-Carbolines As Potential Anticancer Agents

Design, synthesis and mechanism of action of novel 1,9-disubstituted beta-carboline derivatives as antitumor agents

A review of synthetic bioactive tetrahydro-β-carbolines: A medicinal chemistry perspective

Comprehensive construction of biologically active α‐carbolines from synthetic and natural origin

A Review on the Anticancer Activity of Carbazole-based Tricyclic Compounds

Synthesis and biological evaluation of a novel class of beta-carboline derivatives

Design, synthesis and in vitro and in vivo antitumor activities of novel bivalent β-carbolines.

Design, Synthesis, and Biological Evaluation of Novel N-Acylhydrazone Bond Linked Heterobivalent β-Carbolines as Potential Anticancer Agents

Design, Synthesis and Pharmacological Evaluation of Β-Carboline Derivatives As Potential Antitumor Agent Via Targeting Autophagy

Design, Synthesis and in vitro Antitumor Activities of Novel Bivalent beta-Carbolines

An insight into recent developments in imidazole based heterocyclic compounds as anticancer agents: Synthesis, SARs, and mechanism of actions

Synthesis and structure-activity relationships of asymmetric dimeric β-carboline derivatives as potential antitumor agents.

β-Carboline alkaloid monomers and dimers: Occurrence, structural diversity, and biological activities

Synthesis and biological evaluation of novel bivalent beta-carbolines as potential antitumor agents

Synthesis and in Vitro Cytotoxic Evaluation of Novel 3,4, 5-Trimethoxyphenyl Substituted Beta-Carboline Derivatives

Synthesis and biological evaluation of novel 3,9-substituted β-carboline derivatives as anticancer agents

Design, Synthesis, and Antitumor Activity of Β-Carboline- Benzimidazole Hybrids

Functionalization of Tetrahydro-Β-Carbolines for Development of Anticancer Agents

Advances in β-carboline alkaloids from natural products and their biological activities

Synthesis of biaryl-based carbazoles via C-H functionalization and exploration of their anticancer activities